PharmaLex Denmark A/S: Financial statements 2016
CVR: 18652439
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PharmaLex Denmark A/S (CVR 18652439) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 22,356,214 and a net result of DKK 5,319,161 compared with DKK 320,835 the year before. That is an increase of 27.2% compared with the year before. Equity in the 2016 report amounted to DKK 6,597,352. The solvency ratio was 63.6%. The company had 30 employees in the financial year.
- Gross Profit
- DKK 22,356,214
- Profit/Loss
- DKK 5,319,161
- Equity
- DKK 6,597,352
- Total Assets
- DKK 10,367,508
- Employees
- 30
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 22.4 mio. | 5.3 mio. | 6.6 mio. | 30 |
| 2015 | - | 17.6 mio. | 321 t. | 4.9 mio. | - |
| 2014 | - | 15.4 mio. | 2.2 mio. | 6.8 mio. | - |
| 2013 | - | 12.7 mio. | 2.5 mio. | 6.9 mio. | - |
| 2012 | - | 9.9 mio. | 2.3 mio. | 7.2 mio. | - |
Official annual report
Find more companies like PharmaLex Denmark A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 31, 2016, Anette Langgaard Jacobsen has left the board of directors of PharmaLex Denmark A/S.
As of October 20, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of PharmaLex Denmark A/S.
As of October 20, 2016, SØNDERJYLLANDS REVISION STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of PharmaLex Denmark A/S.
As of July 5, 2016, Raphael Troost has joined the board of directors of PharmaLex Denmark A/S.
As of July 5, 2016, Caren Ingrid Martini has joined the board of directors of PharmaLex Denmark A/S.
As of July 5, 2016, Henrik Kagenow has left the board of directors of PharmaLex Denmark A/S.
As of July 5, 2016, Jakob Langgaard Wisnewski has left the board of directors of PharmaLex Denmark A/S.
PharmaLex Denmark A/S has published its annual report for 2015. Gross profit came to DKK 17,574,734, and the net result was DKK 320,835.
As of March 16, 2016, Henrik Kagenow has joined the board of directors of PharmaLex Denmark A/S.
As of March 16, 2016, Anette Langgaard Jacobsen has joined the board of directors of PharmaLex Denmark A/S.
About PharmaLex Denmark A/S
PharmaLex Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 1995. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named JACOBSEN PHARMA CONSULTANCY A/S and SLP NR. 11.026 A/S. The management consists of Åsa Pihlblad. The board consists of Christopher Gauglitz (chair), Carlos Antonio Santaflorentina Juanino and Åsa Pihlblad. The company is owned by Pharmalex Nordic ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 17,235,093 and a net result of DKK -1,712,095 compared with DKK 1,745,746 the year before. Equity in the 2025 report amounted to DKK 2,761,242.